J M Chan

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study
    J M Chan
    Department of Nutrition, Harvard School of Public Health, Boston, USA
    Am J Clin Nutr 74:549-54. 2001
  2. ncbi Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study
    J M Chan
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Science 279:563-6. 1998
  3. ncbi Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
    J Ma
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    J Natl Cancer Inst 91:620-5. 1999
  4. ncbi Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men
    J Ma
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    J Natl Cancer Inst 93:1330-6. 2001
  5. ncbi Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)
    J M Chan
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Cancer Causes Control 11:859-67. 2000
  6. ncbi PSA screening: determinants of primary-care physician practice patterns
    G E Tasian
    Division of Urology, The Children s Hospital of Philadelphia work conducted while at the University of California, San Francisco, CA, USA, Philadelphia, PA, USA
    Prostate Cancer Prostatic Dis 15:189-94. 2012

Detail Information

Publications6

  1. ncbi Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study
    J M Chan
    Department of Nutrition, Harvard School of Public Health, Boston, USA
    Am J Clin Nutr 74:549-54. 2001
    ..The results of epidemiologic studies of this hypothesis are inconclusive...
  2. ncbi Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study
    J M Chan
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Science 279:563-6. 1998
    ..This association was independent of baseline prostate-specific antigen levels. Identification of plasma IGF-I as a predictor of prostate cancer risk may have implications for risk reduction and treatment...
  3. ncbi Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
    J Ma
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    J Natl Cancer Inst 91:620-5. 1999
    ..We therefore examined associations of plasma levels of IGF-I and IGFBP-3 with the risk of colorectal cancer in a prospective case-control study nested in the Physicians' Health Study...
  4. ncbi Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men
    J Ma
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    J Natl Cancer Inst 93:1330-6. 2001
    ..A high ratio of IGF-I to IGF-binding protein-3 (IGFBP-3) has been linked to an increased risk of colorectal cancer...
  5. ncbi Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)
    J M Chan
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Cancer Causes Control 11:859-67. 2000
    ..We examined these nutrients and overall diet and prostate cancer risk in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study (ATBC Study)...
  6. ncbi PSA screening: determinants of primary-care physician practice patterns
    G E Tasian
    Division of Urology, The Children s Hospital of Philadelphia work conducted while at the University of California, San Francisco, CA, USA, Philadelphia, PA, USA
    Prostate Cancer Prostatic Dis 15:189-94. 2012
    ..The effect of practice guidelines and the European Randomised Screening for Prostate Cancer (ERSPC) and Prostate, Lung, Colorectal and Ovarian (PLCO) trials on PSA screening practices of primary-care physicians (PCPs) is unknown...